Gloo Holdings, Inc. Reports Third Fiscal Quarter 2025 Financial Results

Gloo Holdings, Inc. (Nasdaq: GLOO), a leading technology platform for the faith and flourishing ecosystem, today reported financial results for its third quarter ended October 31, 2025. “Q3 marks a solid start as a public company. We delivered very strong revenue growth and continued progress toward profitability, while strategically expanding our platform through the acquisitions […]

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines

(NASDAQ:SFM),(NYSE:AVTR), NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sprouts Farmers Market, Inc. (NASDAQ: SFM) and Avantor, Inc. (NYSE:AVTR). Stockholders have until the deadlines below to petition the court to

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines GlobeNewswire December 17, 2025 NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of

Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% — Hagens Berman

Shareholder rights firm Hagens Berman is scrutinizing Icelandic biopharmaceutical company Alvotech (NASDAQ: ALVO) over the propriety of its disclosures regarding its lead drug candidate and its manufacturing operations, following a dramatic revision to the company's full-year financial forecasts. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The firm urges investors in Alvotech who suffered significant losses to submit your losses now. The

Leading Medical and Public Health Groups Request Transparency, Evidence Behind Changing ACIP Recommendations in Court Hearing

A group of medical professional societies, led by the American Academy of Pediatrics (AAP), today argued in federal court that the changes to vaccine recommendations by the Advisory Committee on Immunization Practices (ACIP), and other actions by HHS Secretary Robert F. Kennedy, Jr. violate the Administrative Procedure Act (APA) and the Federal Advisory Committee Act

Inspire Medical (INSP) Crashes Over 32%, “Inspire V” Launch Failure, Hagens Berman Urges Investors with Losses to Contact Firm by Jan. 5

Partner Reed Kathrein Scrutinizing Alleged Concealment of Billing Code Errors and Inventory Glut Driving 80% Guidance Cut National shareholder rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) is January 5, 2026.

TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 9, 2026. https://mma.prnewswire.com/media/2590203/Hagens_Berman_Sobol_Shapiro_LLP_Logo.jpg The lawsuit follows a series of regulatory setbacks-including an SEC subpoena and

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

(Paris:ABVX),(NasdaqGM:ABVX), Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Breadth of Scientific Evidence: The acceptance of 1 oral presentation, 5 digital oral presentations and 16 posters reflect an expanding dataset for obefazimod, including additional efficacy, safety, and cytokine data from

Federal Realty Completes $170 Million in Asset Dispositions as Part of Capital Recycling Strategy

Federal Realty Investment Trust(NYSE: FRT) today announced the completion of the sale of two assets for combined proceeds of approximately $170 million, consistent with the company's long-term strategy to recycle capital into high-quality and high-growth opportunities. https://mma.prnewswire.com/media/1141400/Federal_1962.jpg The sales include: — Pallas at Pike & Rose (North Bethesda, MD): A stabilized, peripheral residential building delivered

Scroll to Top